{"id":158181,"date":"2014-11-11T14:45:57","date_gmt":"2014-11-11T19:45:57","guid":{"rendered":"http:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/uncategorized\/health-care-sector-update-for-11112014-ptla-icui-enzy-bmy-pfe.php"},"modified":"2014-11-11T14:45:57","modified_gmt":"2014-11-11T19:45:57","slug":"health-care-sector-update-for-11112014-ptla-icui-enzy-bmy-pfe","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/health-care\/health-care-sector-update-for-11112014-ptla-icui-enzy-bmy-pfe.php","title":{"rendered":"Health Care Sector Update for 11\/11\/2014: PTLA, ICUI, ENZY, BMY, PFE"},"content":{"rendered":"<p><p>    Top Health Care Stocks  <\/p>\n<p>    JNJ +0.11%  <\/p>\n<p>    PFE +0.17%  <\/p>\n<p>    ABT +0.58%  <\/p>\n<p>    MRK +1.36%  <\/p>\n<p>    AMGN -0.07%  <\/p>\n<p>    Health care stocks were mostly higher, with the NYSE Health    Care Sector Index adding about 0.5% and shares of health care    companies in the S&P 500 ahead about 0.4% as a group.  <\/p>\n<p>    In company news, Portola Pharmaceuticals ( PTLA ) was see-sawing    between small losses and gains, bouncing back from a steeper    decline earlier Tuesday after the biotech company reported    below-consensus revenue during its July-to-September quarter    while its per-share earnings topped analyst estimates.  <\/p>\n<p>    The company reported a $35.8 million, or $0.86 per share, net    loss, almost double its $18.6 million net loss last year but    still beating the Capital IQ consensus by $0.06 per share.  <\/p>\n<p>    Revenue fell 14.3% compared with the same quarter last year to    $2.4 million as collaboration income from PTLA's work with    Bristol-Myers Squibb Company ( BMY ) and Pfizer (    PFE ), Bayer    Pharma and Janssen Pharmaceuticals, Daiichi Sankyo and Lee's    Pharmaceuticals slid $400,000 from last year. The Street was    looking for $2.63 million in reveneue.  <\/p>\n<p><!-- Auto Generated --><\/p>\n<p>Read more: <\/p>\n<p><a target=\"_blank\" href=\"http:\/\/www.nasdaq.com\/article\/health-care-sector-update-for-11112014-ptla-icui-enzy-bmy-pfe-cm412909\/RK=0\/RS=Tg5nzcpDvijWiY1oPZrTm8eENmU-\" title=\"Health Care Sector Update for 11\/11\/2014: PTLA, ICUI, ENZY, BMY, PFE\">Health Care Sector Update for 11\/11\/2014: PTLA, ICUI, ENZY, BMY, PFE<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p> Top Health Care Stocks JNJ +0.11% PFE +0.17% ABT +0.58% MRK +1.36% AMGN -0.07% Health care stocks were mostly higher, with the NYSE Health Care Sector Index adding about 0.5% and shares of health care companies in the S&#038;P 500 ahead about 0.4% as a group. In company news, Portola Pharmaceuticals ( PTLA ) was see-sawing between small losses and gains, bouncing back from a steeper decline earlier Tuesday after the biotech company reported below-consensus revenue during its July-to-September quarter while its per-share earnings topped analyst estimates <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/health-care\/health-care-sector-update-for-11112014-ptla-icui-enzy-bmy-pfe.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[6],"tags":[],"class_list":["post-158181","post","type-post","status-publish","format-standard","hentry","category-health-care"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/158181"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=158181"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/158181\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=158181"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=158181"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=158181"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}